India to United Arab Emirates: Tiotropium Export Trade Route

The India to United Arab Emirates Tiotropium corridor is one of India's established pharmaceutical export routes, with 127 shipments documented worth a combined $1.6M USD. The route is dominated by VAMSI PHARMA PRIVATE LIMITED, which alone accounts for roughly 58% of all export value, reflecting the consolidated nature of India's tiotropium manufacturing sector.

Across 9 active suppliers, the average shipment value stands at $12.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 77% of all shipments, consistent with tiotropium's non-urgent bulk-order profile.

Shipment activity peaks during April–June, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 12.5%, placing it at rank #2 among India's top tiotropium export destinations globally.

On the import side, key buyers of Indian tiotropium in United Arab Emirates include PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR, M/S.INTAPHARM LABORATORIES FZCO, M/S.INTAPHARMA LABORATORIES FZCO and 12 others. PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is the single largest importer with 2 shipments valued at $669.4K USD.

India's tiotropium exports to United Arab Emirates are driven primarily by a handful of large-scale manufacturers. VAMSI PHARMA PRIVATE LIMITED with 11 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 9 active exporters signals a competitive but concentrated market — buyers in United Arab Emirates benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — VAMSI PHARMA PRIVATE LIMITED, CIPLA LIMITED, ANR HEALTH CARE PRIVATE LIMITED — together account for 99% of total trade value on this route. The average shipment value of $12.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as kp tiova tiotropium bromide rotacaps 18mcg inv qty 116440 pack 1 x 15s 1746600 nos and kp tiova tiotropium bromide rotacaps 18mcg inv qty 116160 pack 1 x 15s 1742400 nos, suggesting that buyers in United Arab Emirates tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, PAYAZ BIOMEDIKAL VE TIBBI CIHAZLAR is the largest importer with 2 shipments worth $669.4K USD — representing 41% of all tiotropium imports from India on this route. A total of 15 buyers are active on this corridor.